This review highlights developments in microfluidic paper-based glucose sensors, emphasizing AI integration and accessibility implications for diabetes management.
Recently, the incidence of diabetes has increased across all socioeconomic groups, with a notable increase in developing countries. Although advances in medical devices have enhanced healthcare accessibility, these benefits remain largely out of reach for individuals residing in remote areas. Concurrently, a variety of devices have been created to detect glucose biomarkers. Among these, microfluidic paper-based sensors have received substantial attention due to their affordability, disposability, and ease of production. Research on microfluidic paper-based glucose sensors has become particularly prominent owing to their considerable potential and wide applicability, especially in the integration of artificial intelligence and machine learning in glucose sensor processing. This review aims to examine recent advancements and progress in the development of microfluidic paper-based glucose sensors over the past five years, highlighting their advantages, limitations, and prospects. The sensors combined with artificial intelligence and machine learning have potential for future applications.
No takes yet. Share an insight, caveat, or question.
Le et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: